1
|
Sia D, Villanueva A, Friedman SL and
Llovet JM: Liver cancer cell of origin, molecular class, and
effects on patient prognosis. Gastroenterology. 152:745–761. 2017.
View Article : Google Scholar : PubMed/NCBI
|
2
|
Avni FE, Massez A and Cassart M: Tumours
of the fetal body: A review. Pediatr Radiol. 39:1147–1157. 2009.
View Article : Google Scholar : PubMed/NCBI
|
3
|
Catanzarite V, Hilfiker M, Daneshmand S
and Willert J: Prenatal diagnosis of fetal hepatoblastoma: Case
report and review of the literature. J Ultrasound Med.
27:1095–1098. 2008. View Article : Google Scholar : PubMed/NCBI
|
4
|
Apte U, Zeng G, Thompson MD, Muller P,
Micsenyi A, Cieply B, Kaestner KH and Monga SP: Beta-catenin is
critical for early postnatal liver growth. Am J Physiol
Gastrointest Liver Physiol. 292:G1578–G1585. 2007. View Article : Google Scholar : PubMed/NCBI
|
5
|
Monga SP: Role and regulation of β-catenin
signaling during physiological liver growth. Gene Expr. 16:51–62.
2014. View Article : Google Scholar : PubMed/NCBI
|
6
|
Tan X, Yuan Y, Zeng G, Apte U, Thompson
MD, Cieply B, Stolz DB, Michalopoulos GK, Kaestner KH and Monga SP:
Beta-catenin deletion in hepatoblasts disrupts hepatic
morphogenesis and survival during mouse development. Hepatology.
47:1667–1679. 2008. View Article : Google Scholar : PubMed/NCBI
|
7
|
Tanimizu N and Miyajima A: Notch signaling
controls hepatoblast differentiation by altering the expression of
liver-enriched transcription factors. J Cell Sci. 117:3165–3174.
2004. View Article : Google Scholar : PubMed/NCBI
|
8
|
Hartmann W, Küchler J, Koch A, Friedrichs
N, Waha A, Endl E, Czerwitzki J, Metzger D, Steiner S, Wurst P, et
al: Activation of phosphatidylinositol-3′-kinase/AKT signaling is
essential in hepatoblastoma survival. Clin Cancer Res.
15:4538–4545. 2009. View Article : Google Scholar : PubMed/NCBI
|
9
|
Testa JR and Tsichlis PN: AKT signaling in
normal and malignant cells. Oncogene. 24:7391–7393. 2005.
View Article : Google Scholar : PubMed/NCBI
|
10
|
Aden DP, Fogel A, Plotkin S, Damjanov I
and Knowles BB: Controlled synthesis of HBsAg in a differentiated
human liver carcinoma-derived cell line. Nature. 282:615–616. 1979.
View Article : Google Scholar : PubMed/NCBI
|
11
|
López-Terrada D, Cheung SW, Finegold MJ
and Knowles BB: Hep G2 is a hepatoblastoma-derived cell line. Hum
Pathol. 40:1512–1515. 2009. View Article : Google Scholar
|
12
|
Capes-Davis A, Theodosopoulos G, Atkin I,
Drexler HG, Kohara A, MacLeod RA, Masters JR, Nakamura Y, Reid YA,
Reddel RR and Freshney RI: Check your cultures! A list of
cross-contaminated or misidentified cell lines. Int J Cancer.
127:1–8. 2010. View Article : Google Scholar : PubMed/NCBI
|
13
|
Crighton D, Wilkinson S, O'Prey J, Syed N,
Smith P, Harrison PR, Gasco M, Garrone O, Crook T and Ryan KM:
DRAM, a p53-induced modulator of autophagy, is critical for
apoptosis. Cell. 126:121–134. 2006. View Article : Google Scholar : PubMed/NCBI
|
14
|
Galavotti S, Bartesaghi S, Faccenda D,
Shaked-Rabi M, Sanzone S, McEvoy A, Dinsdale D, Condorelli F,
Brandner S, Campanella M, et al: The autophagy-associated factors
DRAM1 and p62 regulate cell migration and invasion in glioblastoma
stem cells. Oncogene. 32:699–712. 2013. View Article : Google Scholar : PubMed/NCBI
|
15
|
Klionsky DJ and Emr SD: Autophagy as a
regulated pathway of cellular degradation. Science. 290:1717–1721.
2000. View Article : Google Scholar : PubMed/NCBI
|
16
|
Zhang XD, Qi L, Wu JC and Qin ZH: DRAM1
regulates autophagy flux through lysosomes. PLoS One. 8:e632452013.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Klymkowsky MW and Savagner P:
Epithelial-mesenchymal transition: A cancer researcher's conceptual
friend and foe. Am J Pathol. 174:1588–1593. 2009. View Article : Google Scholar : PubMed/NCBI
|
18
|
Boya P, Reggiori F and Codogno P: Emerging
regulation and functions of autophagy. Nat Cell Biol. 15:713–720.
2013. View
Article : Google Scholar : PubMed/NCBI
|
19
|
Kroemer G, Mariño G and Levine B:
Autophagy and the integrated stress response. Mol Cell. 40:280–293.
2010. View Article : Google Scholar : PubMed/NCBI
|
20
|
Lv Q, Wang W, Xue J, Hua F, Mu R, Lin H,
Yan J, Lv X, Chen X and Hu ZW: DEDD interacts with PI3KC3 to
activate autophagy and attenuate epithelial-mesenchymal transition
in human breast cancer. Cancer Res. 72:3238–3250. 2012. View Article : Google Scholar : PubMed/NCBI
|
21
|
Qiang L, Zhao B, Ming M, Wang N, He TC,
Hwang S, Thorburn A and He YY: Regulation of cell proliferation and
migration by p62 through stabilization of Twist1. Proc Natl Acad
Sci USA. 111:9241–9246. 2014. View Article : Google Scholar : PubMed/NCBI
|
22
|
Catalano M, D'Alessandro G, Lepore F,
Corazzari M, Caldarola S, Valacca C, Faienza F, Esposito V,
Limatola C, Cecconi F and Di Bartolomeo S: Autophagy induction
impairs migration and invasion by reversing EMT in glioblastoma
cells. Mol Oncol. 9:1612–1625. 2015. View Article : Google Scholar : PubMed/NCBI
|
23
|
Li G, Li CX, Xia M, Ritter JK, Gehr TW,
Boini K and Li PL: Enhanced epithelial-to-mesenchymal transition
associated with lysosome dysfunction in podocytes: Role of
p62/sequestosome 1 as a signaling hub. Cell Physiol Biochem.
35:1773–1786. 2015. View Article : Google Scholar : PubMed/NCBI
|
24
|
Gugnoni M, Sancisi V, Gandolfi G, Manzotti
G, Ragazzi M, Giordano D, Tamagnini I, Tigano M, Frasoldati A,
Piana S and Ciarrocchi A: Cadherin-6 promotes EMT and cancer
metastasis by restraining autophagy. Oncogene. 36:667–677. 2017.
View Article : Google Scholar : PubMed/NCBI
|
25
|
Humbert M, Mueller C, Fey MF and Tschan
MP: Inhibition of damage-regulated autophagy modulator-1 (DRAM-1):
Impairs neutrophil differentiation of NB4 APL cells. Leuk Res.
36:1552–1556. 2012. View Article : Google Scholar : PubMed/NCBI
|
26
|
Herzog CE, Andrassy RJ and Eftekhari F:
Childhood cancers: Hepatoblastoma. Oncologist. 5:445–453. 2000.
View Article : Google Scholar : PubMed/NCBI
|
27
|
Darbari A, Sabin KM, Shapiro CN and
Schwarz KB: Epidemiology of primary hepatic malignancies in U.S.
children. Hepatology. 38:560–566. 2003. View Article : Google Scholar : PubMed/NCBI
|
28
|
Xu J, Lamouille S and Derynck R:
TGF-beta-induced epithelial to mesenchymal transition. Cell Res.
19:156–172. 2009. View Article : Google Scholar : PubMed/NCBI
|
29
|
Crighton D, Wilkinson S and Ryan KM: DRAM
links autophagy to p53 and programmed cell death. Autophagy.
3:72–74. 2007. View Article : Google Scholar : PubMed/NCBI
|
30
|
Mah LY, O'Prey J, Baudot AD, Hoekstra A
and Ryan KM: DRAM-1 encodes multiple isoforms that regulate
autophagy. Autophagy. 8:18–28. 2012. View Article : Google Scholar : PubMed/NCBI
|
31
|
Macintosh RL, Timpson P, Thorburn J,
Anderson KI, Thorburn A and Ryan KM: Ryan, Inhibition of autophagy
impairs tumor cell invasion in an organotypic model. Cell Cycle.
11:2022–2029. 2012. View
Article : Google Scholar : PubMed/NCBI
|
32
|
Zhan Z, Xie X, Cao H, Zhou X, Zhang XD,
Fan H and Liu Z: Autophagy facilitates TLR4- and TLR3-triggered
migration and invasion of lung cancer cells through the promotion
of TRAF6 ubiquitination. Autophagy. 10:257–268. 2014. View Article : Google Scholar : PubMed/NCBI
|
33
|
Liu S, Xie F, Wang H, Liu Z, Liu X, Sun L
and Niu Z: Ubenimex inhibits cell proliferation, migration and
invasion in renal cell carcinoma: The effect is
autophagy-associated. Oncol Rep. 33:1372–1380. 2015. View Article : Google Scholar : PubMed/NCBI
|